Arkolith/Insider Trading/RSLS/Form 4

Bandy Barton P.

President and CEO, DirectorReShape Lifesciences Inc. (RSLS) · full profile →Form 4 · filed May 12, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$9K
Net Open-Market Flow
-$9K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 5, 2022Sell(S)11K$0.77$9K808K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001235802-22-000059) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML